Skip to content

Clinical trials

Aspergillosis, Allergic Bronchopulmonary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aspergillosis, Allergic Bronchopulmonary Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20121
20161
20171
20192
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pulmatrix Inc.2
University of Pittsburgh2
Baylor Research Institute1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Regeneron Pharmaceuticals1
Scynexis, Inc.1
University of Alabama at Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aspergillosis, Allergic Bronchopulmonary10
Cystic Fibrosis4
Asthma2
Anemia1
Aspergillosis1
Blastomycosis1
Candidiasis, Chronic Mucocutaneous1
Candidiasis, Invasive1
Candidiasis, Vulvovaginal1
Coccidioidomycosis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.